Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole

Clinical trial NCT04120311 · UNKNOWN

Trial details

NCT number: NCT04120311
Sponsor: Targeted Therapy Technologies, LLC
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Macular Edema Radiation Retinopathy Branch Retinal Vein Occlusion Epiretinal Membrane Central Serous Retinopathy With Pit of Optic Disc Commotio Retinae Vitritis

Start date: 2019-09-01
Primary completion: 2024-09-30
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.